arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Computer Science · Artificial Intelligence

Two-DimensionalElectrophoresisand “Ultrasensitive”SilverStainingof

Cerebrospinalfluidproteinsin Neurologicaldiseases, Michael G. Harrington, Carl R. Merril

See on the map

Abstract

Cerebrospinal fluid (CSF) proteins, as resolved by two-dimensional electrophoresis and made visible by silver stain-ing, have been examined in patients with various neurologi-cal diseases and normal volunteers. The patterns for 15 of 20 patientswith Parkinson’sdiseaseshoweda protein(Mr 25 000) with charge similar to albumin, which was not seen in the patterns for any of 91 normal volunteers. Patterns for 21 of 22 multiple sclerosis patients showed novel immunoglob-ulin light chain proteins, also not present in the CSF of any normal volunteers. Quantitative analysis by computer-assist-ed densitometry in Parkinson’s disease and multiple sclero-sis showed that 20 of 68 and 33 of 85 proteins, respectively, were significantly altered as compared with proteins in the normal population. This ability to characterize both Parkin-son’s disease and multiple sclerosis molecularly provides a broad baseline for improved clinical diagnosis and may serve as an aid in explonng the underlying pathophysiology. These studies illustrate the potential of applying this methodology in the study of neurological diseases. AddItIonal Keyphrases: ner.’ous-system disorders- disease “markers ” Parkinson’s disease multiple sclerosis Examination of cerebrospinal fluid (CSF) is of potential value in searching for changes in neurological diseases because of its clinical availability and its close proximity to the nervous tissue.’ Recently, two-dimensional gel electrophoresis and silver staining of acrylamide gels have enabled over 300 CSF proteins to be examined per individual (1-4). Using this technology, with computer-assisted densitometry (5), we have observed many new protein changes in the CSF from multiple sclerosis (MS) and Parkinson’s disease (PD) pa-tients compared with CSF proteins from both normal volun-teers and patients with other neurological diseases (6, 7). This ability to observe alterations in protein patterns in neurological diseases is based, in part, on studies involving a large group of normal volunteers. Qualitative CSF protein patterns (including 300 proteins per individual) in these normal individuals are highly reproducible. Quantitatively, five of 67 proteins studied showed an alteration with age (8,

More like this